Whether your personal interests are in supporting innovation, bringing lifesaving biomedical products to patients, training the next generation of biomedical leaders or fueling our economy, the Center for Biotechnology provides a vehicle to accomplish great things. Things that matter. Things that change, and save, lives.
Your involvement is an essential part of our future. Please consider a gift to the Center for Biotechnology which will help fuel innovation by ensuring that lifesaving technologies make it out of research labs and into the hands of patients.
Give to the Center for Biotechnology online through the Stony Brook Foundation. Contributions can be made to our Fund for Excellence. More information about donating through the Stony Brook Foundation can be found here.
Funding Opportunity: Gund-Harrington Scholar Award for Fighting Blindness
August 13, 2018
The Gund-Harrington Initiative for Fighting Blindness announces the call for proposals for the 2019 Gund-Harrington Scholar Award.
The Gund-Harrington Scholar Award supports innovative research efforts that could prevent, treat or cure blindness resulting from inherited retinal degenerative diseases. The Gund-Harrington Scholar Award is part of the Gund-Harrington Initiative for Fighting Blindness and sponsored by Foundation Fighting Blindness and Harrington Discovery Institute.
Who should apply?
U.S and Canadian scientists at accredited academic medical centers, research institutions and universities whose discoveries show promise for translation into novel treatments for inherited retinal degenerative diseases.
Multidisciplinary investigators outside the field of retinal disease developing a therapeutic strategy with a potential to benefit inherited retinal degenerative diseases are particularly encouraged to apply.
Multi-Level Support for Award Recipients includes:
Funding totaling up to $900,000 over three years based on progress made towards milestones
Drug development and project management support
Dedicated pharma team for each scholar
Clinical development strategy
Regulatory guidance
Letters of Intent are now being accepted through midnight on October 12, 2018.
Applications are now open for the 12th BioREACH Award Program from the Center for Biotechnology, which provides $50,000 in translational research funding for Stony Brook faculty and postdoctoral researchers to generate the evidence needed to advance promising innovations to the next stage of development.
BioREACH funds milestone-driven studies and welcomes biomedical innovations as well as platforms, tools, computational technologies, and other enabling technologies with the potential to contribute to solutions addressing unmet needs in health.
Application deadline: October 29, 2026, 5:00pm ET
For info sessions, eligibility and deadlines visit our REACH Website and FAQ.
The Center for Biotechnology (CfB) has helped advance some of Stony Brook University’s most impactful biomedical innovations, among them the yeast two-hybrid system, Xiaflex®, ReoPro®, Oracea®, and 3D virtual colonoscopy. The CfB has supported more than 475 faculty-led translational research projects and contributed to 306 license agreements generating $51 million in royalty returns to the University.
Questions? Reach out to our program contacts or sign up for office hours:
The Long Island High Technology Incubator (LIHTI) is inviting innovative and entrepreneurial individuals, with advanced training in STEMM disciplines, to join our team to support our Venture Champions Initiative. The VC Fellowship is powered by the LIHTI team, working collaboratively with a wide network of mentors and industry partners. In the long term, this fellowship aims to generate a pipeline of trained, entrepreneurially-minded fellows as well as a pool of commercially viable technologies for the Long Island Innovation ecosystem. Apply here to chart your commercialization career in hard tech.
[post_title] => LIHTI Venture Champion Fellowship
[post_excerpt] => The Long Island High Technology Incubator is recruiting candidates for its Venture Champions Fellowship.
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => lihti-fellowship24
[to_ping] =>
[pinged] =>
[post_modified] => 2024-12-05 11:36:29
[post_modified_gmt] => 2024-12-05 16:36:29
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://centerforbiotechnology.org/?p=4470
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[2] => WP_Post Object
(
[ID] => 1643
[post_author] => 4
[post_date] => 2015-09-15 18:44:52
[post_date_gmt] => 2015-09-15 18:44:52
[post_content] => Independently documented economic impact: $1.2 BillionJobs created: 1,125New corporate revenues: $812 MillionSupported additional funding: $238 MillionCenter for Biotechnology documented economic impact over recent fifteen-year period
Perhaps it is numbers like these which best illustrate the success CFB has had on the biotechnology industry and economy.
And perhaps they contributed to the redesignation of the CFB as a Center for Advanced Technology for ten years by the New York State Foundation for Science, Technology and Innovation (NYSTAR) as a Center for Advanced Technology (CAT).
The New York State redesignation recognizes the impact of the CFB over 30 years driving innovation toward commercial goals and resulting in accelerated product development cycles "from bench to boardroom to bedside." It recognizes the key role played by the CFB in facilitating a regional bioscience innovation ecosystem, collaborating with Stony Brook University, Cold Spring Harbor Laboratory, and Brookhaven National Laboratory.
The redesignation by New York State validates all of the work we have done over the last 10-year period to create the foundation for exponential growth. We would not have secured the National Institutes of Health REACH award without it, says Clint Rubin, Director of the Center for Biotechnology."The REACH designation represents an $8.1M investment in technology development, commercialization, and new company formation. Visionary's like New York State Senator Kenneth La Valle deserve the credit. They recognized thirty years ago that universities represented a largely untapped pool of innovation and economic potential.
Strikingly, it validates and provides the foundation for the new Long Island Bioscience Hub (LIBH), a CFB-led initiative to formally bring these institutions together to foster technology development, commercialization, and new company formation. The LIBH is a bold step made possible by a partnership with the National Institute of Health REACH initiative (Research Evaluation and Commercialization Hub). The NIH award places the CFB in the national spotlight along with other elite institutions. (Read more on the NIH REACH award here)
"This redesignation occurs in an interesting and changing environment, where varying elements in the regional, state, and national biotech ecosystem are aligning. There is a confluence of events and issues that are creating a unique opportunity to build the biotech economy in the region and across the State." Commented Diane Fabel, Director of Operations, CFB. "We have learned a lot about the process of moving academic innovation into the commercial sector over time. And there have been such tremendous scientific advances recently that represent new commercial opportunities and life saving technologies. There is still much to learn and do, and it is an incredibly exciting time to be doing it.
[post_title] => Center for Biotechnology Redesignated by New York State: 'Unique Time of Change and Growth'
[post_excerpt] => The New York State redesignation recognizes the impact of the CFB over 30 years driving innovation toward commercial goals and resulting in accelerated product development cycles from bench to boardroom to bedside.
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => center-for-biotechnology-redesignated-by-new-york-state-unique-time-of-change-and-growth
[to_ping] =>
[pinged] =>
http://centerforbiotechnology.org/new/center-for-biotech-receives-nih-award-to-develop-a-bioscience-hub/
[post_modified] => 2016-03-02 17:48:17
[post_modified_gmt] => 2016-03-02 17:48:17
[post_content_filtered] =>
[post_parent] => 0
[guid] => http://centerforbiotechnology.org/new/?p=1643
[menu_order] => 200
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[3] => WP_Post Object
(
[ID] => 4957
[post_author] => 4
[post_date] => 2026-01-06 14:16:00
[post_date_gmt] => 2026-01-06 19:16:00
[post_content] =>
Dr. Gurtej Singh, Research Associate Professor of Surgery at the Renaissance School of Medicine, was awarded seed funding through the SUNY Technology Accelerator Fund (TAF) to advance DEVA — a vascularized, shelf-stable skin substitute for advanced wound care. This bio-printed, multilayered construct integrates embedded vascular networks and antimicrobial features to enhance healing for chronic and hard-to-treat wounds — with the potential to shorten healing timelines and improve patient outcomes.
Additionally, Dr. Anurag Purwar, associate professor in the Department of Mechanical Engineering in Stony Brook’s College of Engineering and Applied Sciences, was one of four SUNY Mission TAF awardees for his research, MotionGen — An AI Platform for Intelligent Mechanism Design in Robotics. Purwar is launching an enterprise version of MotionGen, a cloud-based AI platform that automates the robot mechanism design, reducing costs and improving quality through enhanced visualization and intelligent synthesis tools.
The SUNY TAF supports early-stage innovations with strong commercial potential, helping faculty move technologies from the lab toward real-world impact. This funding — part of a competitive award portfolio — underscores how translational research at Stony Brook continues to bridge discovery science and high-impact biotechnology solutions. Read more about these innovators and the TAF awards on SBU News.
Applications are now open for the 12th BioREACH Award Program from the Center for Biotechnology, which provides $50,000 in translational research funding for Stony Brook faculty and postdoctoral researchers to generate the evidence needed to advance promising innovations to the next stage of development.
BioREACH funds milestone-driven studies and welcomes biomedical innovations as well as platforms, tools, computational technologies, and other enabling technologies with the potential to contribute to solutions addressing unmet needs in health.
Application deadline: October 29, 2026, 5:00pm ET
For info sessions, eligibility and deadlines visit our REACH Website and FAQ.
The Center for Biotechnology (CfB) has helped advance some of Stony Brook University’s most impactful biomedical innovations, among them the yeast two-hybrid system, Xiaflex®, ReoPro®, Oracea®, and 3D virtual colonoscopy. The CfB has supported more than 475 faculty-led translational research projects and contributed to 306 license agreements generating $51 million in royalty returns to the University.
Questions? Reach out to our program contacts or sign up for office hours:
